SKI Market

Indian Indices

Nifty

25,722.10 -155.75
(-0.60%)

Sensex

83,938.71 -465.75
( -0.55%)

Bank Nifty

57,776.35 -254.75
( -0.44%)

Nifty IT

35,712.35 -194.05
( -0.54%)

Global Indices

Nasdaq

47,580.95 37.83
(0.08%)

Dow Jones

6,861.23 17.89
(0.26%)

Hang Seng

52,282.77 957.16
(1.86%)

Nikkei 225

9,715.58 -44.48
(-0.46%)

Forex

USD-INR

88.57 0.35
(0.39%)

EUR-INR

102.67 0.05
(0.05%)

GBP-INR

116.69 0.04
(0.03%)

JPY-INR

0.58 0.00
(-0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

IBL Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

91871

INE0O7401018

23.7179573

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IBLFL

71.26

167.43

EPS(TTM)

Face Value()

Div & Yield %

0.95

Back

biogen pharmachem industries ltd

Citizen Infoline standalone net profit rises 200.00% in the June 2025 quarter

Jul 29,2025

Net profit of Citizen Infoline rose 200.00% to Rs 0.03 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter ended June 2024. Sales rose 70.89% to Rs 1.35 crore in the quarter ended June 2025 as against Rs 0.79 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	1.35	0.79	71
OPM %	2.22	-10.13	-
PBDT	0.03	0.01	200
PBT	0.03	0.01	200
NP	0.03	0.01	200

25,722.10 -155.75 (-0.60%)

83,938.71 -465.75 ( -0.55%)

57,776.35 -254.75 ( -0.44%)

35,712.35 -194.05 ( -0.54%)

47,580.95 37.83 (0.08%)

6,861.23 17.89 (0.26%)

52,282.77 957.16 (1.86%)

9,715.58 -44.48 (-0.46%)

88.57 0.35 (0.39%)

102.67 0.05 (0.05%)

116.69 0.04 (0.03%)

0.58 0.00 (-0.51%)